Jan. 16, 2025
| Today’s news and insights for medtech leaders
Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.
|
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
|
A report found China limits EU-based device manufacturers’ access to its market through policies that favor local suppliers in an “unfair and discriminatory way.”
|
Tell your brand’s story. Secure prime ad placements. Generate qualified leads. Reach your marketing goals with MedTech Dive’s audience of over 206,500 decision makers.
|
Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.
|
At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.
|
|
Getting your medical device to market takes purpose-built technology and strategic planning. This guide explores clinical trial complexities, including regulatory trends, best practices and must-have tools.
|
|
From Our Library
Trendline
Supported by IQVIA
|
Playbook
Custom content for Avania
|
View all resources
What We're Reading
Fierce Biotech
|
| 
